EN
HI
Summary
As of 20 Sep, 2026, Astrazeneca Pharma India stock price is ₹6751.5. During the trading session, the stock has moved between an intraday low of ₹6678.00 and an intraday high of ₹6769.00. Over the last 52 weeks, Astrazeneca Pharma India has traded between ₹6600.00 and ₹9849.50.
The stock has recorded a trading volume of 4,635 shares,. Its Average Traded Price (ATP) is ₹6737.38, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 1 @ ₹6751.50.
Astrazeneca Pharma India has an upper circuit limit of ₹8101.50 and a lower circuit limit of ₹5401.50. The total value traded stands at ₹3.12 CR, and the delivery percentage for the day is 41.62%.
The stock is currently traded with a market lot size of 1. Astrazeneca Pharma India also offers a dividend yield of 0%.
Astrazeneca Pharma India Share Price Chart
Astrazeneca Pharma India Share Key Metrics
Volume
4635.00
Market Cap
16878.75 CR
LTQ@LTP
1@6751.50
ATP
6737.38
Var Margin
14.65 %
Circuit Range
5401.5-8101.5
Delivery %
41.62 %
Value
3.12 CR
ASM/GSM
No
Market Lot
1
Astrazeneca Pharma India Resistance and Support
Pivot 6692.33
Resistance
First Resistance
6729.66
Second Resistance
6790.33
Third Resistance
6827.66
Support
First Support
6631.66
Second Support
6594.33
Third Support
6533.66
Astrazeneca Pharma India Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Fri Sep 18 2026 | 6678 | 6751.5 | 1.24% | 6769 | 6678 |
| Thu Sep 17 2026 | 6700 | 6669 | -0.51% | 6753 | 6655 |
| Wed Sep 16 2026 | 6671 | 6703 | 0.11% | 6898.5 | 6650.5 |
Astrazeneca Pharma India Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-10 | Quarterly Results |
| 2026-05-26 | Audited Results & Final Dividend |
| 2026-02-11 | Quarterly Results |
| 2025-11-07 | Quarterly Results |
| 2025-08-14 | Quarterly Results |
| 2025-05-30 | Audited Results & Dividend |
| 2025-02-11 | Quarterly Results |
| 2024-11-13 | Quarterly Results |
| 2024-08-08 | Quarterly Results |
Astrazeneca Pharma India News
AstraZeneca Pharma India Ltd - 506820 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Disclosure Of ESG Rating
AstraZeneca Pharma received an ESG rating of 57 from Crisil ESG Ratings. The rating was based on publicly available information, and the company clarified they did not engage Crisil for this assessment.
Aug 24 2026 20:52:14
AstraZeneca Pharma India Ltd - 506820 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
AstraZeneca Pharma India Limited has scheduled a virtual one-on-one interaction with an institutional investor on August 26, 2026. This meeting is part of the company's ongoing engagement with the investment community.
Aug 21 2026 22:24:10
Astrazeneca Pharma India Management
| Name | Position |
|---|---|
| Shilpa Divekar Nirula | Chairperson |
| Revathy Ashok | Non Executive Independent Director |
Astrazeneca Pharma India Similar Stocks
Neuland Laboratories Ltd.
22840.00
175.00 (0.77%)
Acutaas Chemicals Ltd.
3440.30
125.20 (3.78%)
Piramal Pharma Ltd.
208.16
3.45 (1.69%)
Granules India Ltd.
875.50
5.10 (0.59%)
Caplin Point Laboratories Ltd.
2748.60
152.00 (5.85%)
Pfizer Ltd.
4002.40
-12.40 (0.31%)
Onesource Specialty Pharma Ltd.
1594.90
14.90 (0.94%)
Shilpa Medicare Ltd.
1021.10
62.75 (6.55%)
Eris Lifesciences Ltd.
1321.30
10.60 (0.81%)
Poly Medicure Ltd.
1726.00
13.30 (0.78%)
Astrazeneca Pharma India FAQs
The Buying Price of Astrazeneca Pharma India share is 6751.5 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Astrazeneca Pharma India stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Astrazeneca Pharma India, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Astrazeneca Pharma India shares is 0. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Astrazeneca Pharma India shares is 0. Useful to assess the stock's value relative to its book value.
To assess Astrazeneca Pharma India’s valuation compare Sector P/E, P/B which are 42.35 & 3.61 with sector averages, along with growth rates and financial metrics.
The Market Cap of Astrazeneca Pharma India is 16878.75 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Astrazeneca Pharma India share price is 9849.50 & 6600.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Astrazeneca Pharma India belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in ASTRAZEN
